Fig. 6
(A) Cumulative incidence for LRR in the overall population. (B) Cumulative incidence for LRR in EGFR wild-type patients. (C) Cumulative incidence for LRR in EGFR mutant patients. (D) Cumulative incidence for LRR in PD-L1 positive patients. (E) Cumulative incidence for LRR in PD-L1 negative patients